Literature DB >> 1835279

Prognostic features of children with idiopathic dilated cardiomyopathy.

H B Wiles1, P D McArthur, A B Taylor, P C Gillette, D A Fyfe, J P Matthews, L W Shelton.   

Abstract

The presenting features and long-term outcome of 39 children (median age 6.5 months, range 1 day to 16 years) with idiopathic dilated cardiomyopathy (IDC) were reviewed to help determine the appropriate management of these patients. Four outcome groups were identified: those who died, improved, had IDC resolved or received transplants. Presenting clinical features of age, sex, race, congestive heart failure, cardiomegaly, and degree of systolic ventricular dysfunction did not predict final outcome. Left ventricular hypertrophy on the electrocardiogram was seen significantly more often in children who improved than in those who died or in whom IDC resolved (p = 0.002). A rhythm disturbance was also seen more often in those who died than in those who survived (p = 0.025). Of 36 patients treated medically, 12 (33%) died, 15 (42%) improved and 9 (25%) resolved. Eighteen of 26 (69%) patients presenting at age less than or equal to 2 years survived, whereas 6 of 10 patients greater than 2 years survived. There were no differences based on age at presentation, in the time to death or time of follow-up. Three patients received orthotopic heart transplants, 1 of whom died from graft failure. Thus, no clinical feature including age at presentation consistently predicts ultimate outcome in children with IDC.

Entities:  

Mesh:

Year:  1991        PMID: 1835279     DOI: 10.1016/0002-9149(91)90248-j

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

1.  Impaired cardiac adrenergic innervation assessed by MIBG imaging as a predictor of treatment response in childhood dilated cardiomyopathy.

Authors:  P Acar; P Merlet; L Iserin; D Bonnet; D Sidi; A Syrota; J Kachaner
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

2.  Superselective Intra-arterial Thrombolysis for Acute Cardioembolic Stroke in a Child with Idiopathic Dilated Cardiomyopathy. A Case Report.

Authors:  E Kitzmüller; A Gruber; M Marx; M Schlemmer; M Wimmer; B Richling
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

Review 3.  Genetic abnormalities responsible for dilated cardiomyopathy.

Authors:  J A Towbin; N E Bowles
Journal:  Curr Cardiol Rep       Date:  2000-09       Impact factor: 2.931

Review 4.  A practical approach for the diagnosis and management of dilated cardiomyopathy.

Authors:  R Krishna Kumar
Journal:  Indian J Pediatr       Date:  2002-04       Impact factor: 1.967

5.  Predictors of outcome of myocarditis.

Authors:  B Kühn; E D Shapiro; T A Walls; A H Friedman
Journal:  Pediatr Cardiol       Date:  2004 Jul-Aug       Impact factor: 1.655

6.  Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23.

Authors:  K R Bowles; R Gajarski; P Porter; V Goytia; L Bachinski; R Roberts; R Pignatelli; J A Towbin
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

7.  Use of 123I-MIBG scintigraphy to assess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy.

Authors:  Christophe Maunoury; Philippe Acar; Daniel Sidi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-09-23       Impact factor: 9.236

8.  Outcome Predictors for Pediatric Dilated Cardiomyopathy: A Systematic Review.

Authors:  Jorge A Alvarez; James D Wilkinson; Steven E Lipshultz
Journal:  Prog Pediatr Cardiol       Date:  2007-09-01

9.  Dilated cardiomyopathy in children: clinical course and prognosis.

Authors:  A Ciszewski; Z T Bilinska; B Lubiszewska; E Ksiezycka; W Poplawska; E Michalak; E Walczak; F Walczak; W Ruzyllo
Journal:  Pediatr Cardiol       Date:  1994 May-Jun       Impact factor: 1.655

10.  Mapping a cardiomyopathy locus to chromosome 3p22-p25.

Authors:  T M Olson; M T Keating
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.